Treatment of Viral Hemorrhagic Fever in a Well-Resourced Environment

Chapter

Abstract

Evaluation and management of a patient with a potentially highly infectious disease, such as Ebola Virus Disease, requires a structured and thoughtful approach. The differential diagnosis in such cases will include potentially life-threatening diseases that require rapid diagnosis and early initiation of therapy. However, these goals must be balanced with the need to preserve the safety of providers and other patients.

During known outbreaks, active screening for compatible symptoms and exposure history can allow early isolation of potentially contagious individuals, and thus limit the exposure to providers and other patients. If clinical suspicion remains, evaluation can be carried out under appropriate isolation precautions, by providers who have been trained in those precautions.

For the most part, the management strategy will not be dramatically different than in other critical illnesses: resuscitation to support organ function while targeted therapies address the underlying cause. However, some aspects of critical care may be significantly altered by the necessary safety precautions. Some examples include specimen collection and handling, decontamination of equipment, waste management, team structure, bedside assessment, hemodynamic and respiratory monitoring, diagnostic imaging, and invasive procedures. Deviations from regular workflow can potentially represent a risk to the patient and providers. Thus, advance development of clinical protocols and using drills with simulation to refine practice can mitigate risk to providers.

Keywords

Ebola Africa Critical care Outbreak Viral hemorrhagic fever 

References

  1. 1.
    West TE, von Saint Andre-von Arnim A. Clinical presentation and management of severe Ebola virus disease. Ann Am Thorac Soc. 2014;11(9):1341–50.CrossRefPubMedGoogle Scholar
  2. 2.
    Centers for Disease Control. [Internet]. Ebola virus disease: US healthcare workers and settings (accessed 10 June 2015]. Available for: http://www.cdc.gov/vhf/ebola/healthcare-us/index.html.
  3. 3.
    World Health Organization [Internet]. Interim infection prevention and control guidance for care of patients with suspected or confirmed filovirus haemorrhagic fever in health-care settings, with focus on Ebola [accessed 10 June 2015]. Available from: http://www.who.int/csr/disease/ebola/evd-guidance-summary/en/.
  4. 4.
    Beeching NJ, et al. Ebola virus disease. BMJ. 2014;349:g7348.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Lyon GM, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med. 2014;371:2402–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Hampton T. Vaccines against Ebola and Marburg viruses show promise in primate studies. JAMA. 2005;294(2):163–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Rosenbaum L. License to serve – U.S. trainees and the Ebola epidemic. N Engl J Med. 2015;372:504–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Gonsalves G, Staley P. Panic, paranoia, and public health – the AIDS epidemic’s lessons for Ebola. N Engl J Med. 2014;371:2348–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Hampton T. Largest-ever outbreak of Ebola virus disease thrusts experimental therapies, vaccines into spotlight. JAMA. 2014;312:987–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Division of Pulmonary, Critical Care, and Sleep MedicineNew York University School of MedicineNew YorkUSA

Personalised recommendations